Home/Filings/4/0001140361-17-028895
4//SEC Filing

Andrews Timothy K. 4

Accession 0001140361-17-028895

CIK 0001656328other

Filed

Jul 26, 8:00 PM ET

Accepted

Jul 27, 4:23 PM ET

Size

5.7 KB

Accession

0001140361-17-028895

Insider Transaction Report

Form 4
Period: 2017-07-26
Andrews Timothy K.
General Counsel & Secretary
Transactions
  • Award

    Stock Option (Right to Buy)

    2017-07-26+8,5188,518 total
    Exercise: $15.00Exp: 2027-07-26Common Stock (8,518 underlying)
Footnotes (1)
  • [F1]Twenty-five percent (25%) of the shares subject to the option vest and become exercisable on the first anniversary measured from July 26, 2017, and the remaining shares subject to the option vest and become exercisable in 36 successive, equal monthly installments thereafter, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.

Documents

1 file

Issuer

Sienna Biopharmaceuticals, Inc.

CIK 0001656328

Entity typeother

Related Parties

1
  • filerCIK 0001711464

Filing Metadata

Form type
4
Filed
Jul 26, 8:00 PM ET
Accepted
Jul 27, 4:23 PM ET
Size
5.7 KB